Andrew J Tebben is a notable inventor based in Wallingford, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of human receptor tyrosine kinases. With a total of 5 patents to his name, Tebben's work has had a considerable impact on medical research and therapeutic development.

Latest Patents

One of his latest patents involves the human receptor tyrosine kinase, KDR. This patent discloses an isolated nucleic acid molecule encoding a novel human receptor type tyrosine kinase gene, KDR. The isolation of this KDR cDNA sequence results in the disclosure of purified forms of human KDR protein, recombinant vectors, and recombinant hosts that express human KDR. This innovation is crucial for advancing our understanding of receptor tyrosine kinases and their role in various biological processes.

Career Highlights

Andrew J Tebben is currently associated with Merck & Company, Inc., where he continues to push the boundaries of scientific research. His work at Merck has allowed him to collaborate with leading experts in the field and contribute to groundbreaking discoveries.

Collaborations

Some of his notable coworkers include Richard L Kendall and Xianzhi Mao. Their collaborative efforts have further enhanced the research output and innovation at Merck.

Conclusion

In summary, Andrew J Tebben is a distinguished inventor whose work in receptor tyrosine kinases has paved the way for advancements in biotechnology. His contributions are invaluable to the scientific community and continue to inspire future innovations.

Profile summary based on public USPTO records.